The pharmaceutical world is currently reeling from the news that the FDA’s Center for Drug Evaluation and Research (CDER) has proposed a full market withdrawal of Tavneos (avacopan). The drug manufacturer, Amgen, is embroiled with the FDA in the dispute about the withdrawal of Tavneos.
follow.it gives you an easy way to subscribe to Onbiostatistics's news feed! Click on Follow below and we deliver the updates you want via email, phone or you can read them here on the website on your own news page.
You can also unsubscribe anytime painlessly. You can even combine feeds from Onbiostatistics with other site's feeds!
Title: On Biostatistics and Clinical Trials